(±)-MDMA and its enantiomers: potential therapeutic advantages of R(−)-MDMA

@article{Pitts2017MDMAAI,
  title={(±)-MDMA and its enantiomers: potential therapeutic advantages of R(−)-MDMA},
  author={Elizabeth G. Pitts and Daniel W Curry and Karly Hampshire and Matthew B. Young and Leonard Lee Howell},
  journal={Psychopharmacology},
  year={2017},
  volume={235},
  pages={377-392}
}
The use of (±)-3,4-methylenedioxymethamphetamine ((±)-MDMA) as an adjunct to psychotherapy in the treatment of psychiatric and behavioral disorders dates back over 50 years. Only in recent years have controlled and peer-reviewed preclinical and clinical studies lent support to (±)-MDMA’s hypothesized clinical utility. However, the clinical utility of (±)-MDMA is potentially mitigated by a range of demonstrated adverse effects. One potential solution could lie in the individual S(+) and R… 
MDMA and memory, addiction, and depression: dose-effect analysis
TLDR
The present dose-ranging study provides further evidence that 3 mg/kg is the threshold for MDMA-induced amnesia and demonstrates that careful selection of MDMA dose is critical.
Methylenedioxymethamphetamine (MDMA) in Psychiatry: Pros, Cons, and Suggestions
TLDR
The proposed potential of MDMA as an adjunct to psychotherapy for PTSD is evaluated and suggestions of alternative treatments based on the behavioral pharmacology and toxicology of MDMA and its enantiomers are presented.
Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.
TLDR
The synthesis of MDMA is detailed as well as its pharmacology, metabolism, adverse effects, and potential use in medicine, which discusses its history and why it is perhaps the most important compound for the future of psychedelic science.
Acute Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and R(-) MDMA on Actigraphy-Based Daytime Activity and Sleep Parameters in Rhesus Monkeys
TLDR
Although afternoon administration of racemic MDMA increased sleep latency, it improved other sleep parameters, decreasing wake time after sleep onset (WASO) and increasing sleep efficiency for subjects with low baseline sleep efficiency, while having no effects on daytime activity.
Better living through chemistry: MDMA’s prosocial mechanism as a starting point for improved therapeutics
TLDR
It is predicted that perhaps a 5-HTR1b agonist or even d-fenfluramine, in the context of psychotherapy, could produce beneficial subjective effects similar to MDMA while minimizing the addictive potential.
Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose
TLDR
No evidence that doses of less than 3 mg/kg MDMA—the dose range that users typically take—produce cognitive deficits in animals is found, and the short-term, infrequent, therapeutic use of ultra low-dose MDMA is unlikely to pose significant cognitive risks.
MDMA – hopes and fears associated with therapeutic use in mental disorders
TLDR
It seems that further studies are needed to determine the long-term safety and effectiveness of MDMA assisted psychotherapy, as data available in the literature suggest that psychoactive substances may be safely administered in clinical settings.
Worsening of the Toxic Effects of (±)Cis-4,4′-DMAR Following Its Co-Administration with (±)Trans-4,4′-DMAR: Neuro-Behavioural, Physiological, Immunohistochemical and Metabolic Studies in Mice
TLDR
The study demonstrated that the (±)cis stereoisomer dose-dependently induced psychomotor agitation, sweating, salivation, hyperthermia, stimulated aggression, convulsions and death.
...
1
2
...

References

SHOWING 1-10 OF 170 REFERENCES
In vivo pharmacology of MDMA and its enantiomers in rhesus monkeys.
  • W. Fantegrossi
  • Biology
    Experimental and clinical psychopharmacology
  • 2008
TLDR
This review attempts to cover the author's research into the in vivo effects of MDMA and its enantiomers, as well as other relevant publications which pertain to this topic, to caution that any results obtained in vivo with the MDMA enantiomer may not be particularly informative with regards to the racemate and vice versa.
Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects.
TLDR
The short-term administration of MDMA produced marked euphoria, a slight impairment in the performance of psychomotor tasks, and mild changes in body perceptions without hallucinations, which support the abuse liability of MDMA.
The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder
TLDR
The limitations on retrospective human studies and preclinical animal models of MDMA neurotoxicity are examined and the possible neurochemical mechanisms involved in MDMA’s efficacy in treating PTSD are reviewed.
Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans
TLDR
Differences in personality support the view that 5-HT systems are involved in modulating impulsive and aggressive personality traits and suggest that5-HT neurotoxicity may be a potential complication of MDMA use.
Characterization of 3,4-Methylenedioxymethamphetamine (MDMA) Enantiomers In Vitro and in the MPTP-Lesioned Primate: R-MDMA Reduces Severity of Dyskinesia, Whereas S-MDMA Extends Duration of ON-Time
TLDR
It is suggested that racemic MDMA exerts simultaneous effects, reducing dyskinesia and extending ON-time, by 5-HT2A antagonism and SERT-selective mixed monoamine uptake inhibition, which arise from its R and S enantiomers, respectively.
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
TLDR
Evidence for the occurrence of MDMA-induced neurotoxic damage in human users remains equivocal, although some biochemical and functional data suggest that damage may occur in the brains of heavy users.
Estimating the relative reinforcing strength of (±)-3,4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine
TLDR
Self-administration of MA, MDMA, and its isomers using a progressive-ratio schedule in rhesus monkeys supported the hypothesis that increasing 5-HT releasing potency relative to DA is associated with weaker reinforcing effects.
Safety pharmacology of acute MDMA administration in healthy subjects
TLDR
MDMA administration was overall safe in physically and psychiatrically healthy subjects and in a medical setting, however, the risks of MDMA are likely higher in patients with cardiovascular disease and remain to be investigated in Patients with psychiatric disorders.
The Nature of 3, 4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonergic Dysfunction: Evidence for and Against the Neurodegeneration Hypothesis
TLDR
The aim of this review is to address both sides of the MDMA-neurotoxicity controversy, including recent findings from the laboratory regarding the potential of MDMA to induce serotonergic damage in a rat binge model, and to add to the growing literature implicating neuroregulatory mechanisms underlying MDMA-induced Serotonergic dysfunction.
...
1
2
3
4
5
...